By: Charles Reznikoff, MD, Addiction Specialist, Hennepin Healthcare
Earn 1 CEU, pre-approved for Social Workers by BOSW; self-submit other disciplines.
MGS is listed as a Continuing Education Resource by the MN Board of Nursing.
(The CEU is free for MGS members; $15 for non-members.)
Whether you’re for it, against it, or decidedly undecided, the reality is that the legalization of marijuana — both for medicinal and recreational purposes — is on the rise. One less-than-likely segment of the population picking up in their usage of medical marijuana? The 65-and-older set. This webinar will present an overview and update of how the Minnesota Medical Cannabis program functions, who is eligible, and important contraindications to consider for older patients.
In 2014 the Minnesota legislature created a process allowing seriously ill Minnesotans to use medical cannabis to treat certain conditions, and starting in August 2019, Alzheimer’s Disease will be added as a qualifying condition. While the anecdotal evidence is strong for the use of medical marijuana and CBD for pain control, anxiety, cancer, etc., the status of research has been limited under federal law and there are few studies addressing how it affects the older population.
- Understand the difference between CBD and THC
- Understand the known benefits of medical cannabis
- Understand the risks and contraindications of medical cannabis
Charles Reznikoff, MD, Addiction Specialist, Hennepin Healthcare
Dr. Charles Reznikoff is an internal medicine and addiction medicine doctor at Hennepin Healthcare. He has served on the governors medical cannabis task force, written the HCMC policy on medical cannabis, and offers many lectures on the topic. He also treats opioid addiction, alcohol addiction, and serves as a hospitalist eight weeks a year.
- Fact Sheet on the Minnesota Medical Cannabis Program
- Minnesota Department of Health – Medical Cannabis Program
- National Council for Aging Care
- Should Physicians Recommend Replacing Opioids with Cannabis?